Skip to content

AdaptVac vs HilleVax

AdaptVac logo

AdaptVac

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines

10 employees · est. 2017 · Horsholm, Denmark

VS
HilleVax logo

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines

76 employees · est. 2021 · Boston, United States

AdaptVac is the older company (2017 vs 2021); HilleVax is the larger of the two.

Side-by-Side Comparison

AdaptVac HilleVax
Founded
2017 older 2021
Headquarters
Horsholm, Denmark Boston, United States
Employees
10 76 larger
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Grant Post-IPO Equity
Total Funding
$800.00K $235.00M
Funding Rounds
1 2
Taxonomy
Vaccine DevelopmentTherapeutic VaccinesProphylactic VaccinesInfectious DiseasesCancer TreatmentImmune Therapy +8 BiopharmaceuticalVaccine DevelopmentNovel VaccinesVirus-like Particle (VLP) VaccineGastroenteritis PreventionNorovirus +9
Website
adaptvac.com hillevax.com
AdaptVac logo

About AdaptVac

AdaptVac is a biotechnology startup with a strong focus on accelerating the development of safe and efficacious therapeutic and prophylactic vaccines. Founded in 2017, the company is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Va...

HilleVax logo

About HilleVax

HilleVax is a biopharmaceutical company founded in 2021 with a focus on the development and commercialization of novel vaccines. The company's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norov...

Also comparing in this category

Comparing more than these two?

Get AdaptVac, HilleVax and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does AdaptVac compare?

A PDF of AdaptVac and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

AdaptVac was founded in 2017, based in Horsholm, Denmark, with 10 employees. AdaptVac is a biotechnology startup with a strong focus on accelerating the development of safe and efficacious therapeutic and prophylactic vaccines. Founded in 2017, the company is a joint-venture b. HilleVax was founded in 2021, based in Boston, United States, with 76 employees. HilleVax is a biopharmaceutical company founded in 2021 with a focus on the development and commercialization of novel vaccines. The company's initial program, HIL-214, is a virus-like particle (VLP).
AdaptVac has raised $800.00K and HilleVax $235.00M. Latest stage: AdaptVac Grant, HilleVax Post-IPO Equity.
Both work in Biotechnology and Health Care and list vaccine development among their focus areas.

Compare AdaptVac with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AdaptVac on 12 Sep 2024, and HilleVax on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout